Hospira Inc. recalls 5% Lidocaine HCL and 7.5% Dextrose Injection, USP, 2 mL Single-dose ampule, 5 count box, Rx Only, For Spinal Anesthesia
Recalled December 14, 2016 · FDA recall D-0169-2017 · Hospira
Hazard
Failed Stability Specifications: The recalled lots did not meet the specification for color and pH throughout shelf life. · FDA Class III
Units
287,200 2 mL ampules
Sold at
US and Puerto Rico
Description
Failed Stability Specifications: The recalled lots did not meet the specification for color and pH throughout shelf life.
Product
5% Lidocaine HCL and 7.5% Dextrose Injection, USP, 2 mL Single-dose ampule, 5 count box, Rx Only, For Spinal Anesthesia Only, Manufactured by Hospira, Inc., Lake Forest, IL 60045, NDC 0409-4712-01
Manufacturer(s)
Hospira Inc.
Source: U.S. Food and Drug Administration. Official recall notice on fda.gov →